NUDT15 and acute lymphoblastic leukemia: Studying the frequency of polymorphisms of the NUDT15 not only helps in the dosing of 6MP in patients with ALL, but it may also give an idea of its frequency in patients with inflammatory bowel diseases (IBD) and rheumatoid arthritis to avoid thiopurine-induced toxicity.